article thumbnail

LabCorp Backs Resolution Bioscience’s Liquid Biopsy Test for NSCLC

XTalks

The leading global life science company is set to introduce Resolution Bio’s ctDx Lung assay , a non-invasive liquid biopsy test for patients with non-small cell lung cancer (NSCLC). LabCorp (NYSE:LH) may help lead the way with its backing of Resolution Bioscience’s new diagnostic blood test for lung cancer.

Gene 105
article thumbnail

How Pharmacogenomics may finally realise its promise

pharmaphorum

The program is orchestrated by Coriell Life Sciences, and nearly half of the 5,000 enrolled members have already made immediate shifts to their medication regimen which are showing positive results, both from an individual impact as well as a cost-savings perspective.

Genome 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Study Suggests Pregnant Women Should Avoid Caffeine Altogether. Here’s Why

XTalks

The results did not differ based on fast or slow caffeine metabolism genotype. Increasing caffeine amounts were significantly associated with lower birth weight, shorter length and smaller head, arm, and thigh circumference.

article thumbnail

Why Proviral DNA Drug Resistance Testing is Useful in Guiding Treatment Decisions for HIV-1 Patients

XTalks

Proviral DNA Genotyping. In the HIV space, proviral DNA resistance testing is the newest genotypic resistance testing to be incorporated into the day-to-day management of patients living with HIV, explains Dr. Walworth. Importantly, ARV treatment does not affect the proviral DNA genome that persists in latently infected cells.

DNA 98
article thumbnail

Biorepositories as a Guiding Resource for Research & Drug Discovery

XTalks

Through these collaborations, cohort research dataset sharing programs allow for whole-genome sequence and genotype data to be made available for independent research. Now, if all you’ve already got is a bioresource of 20,000 people that have already been genotyped, you can choose those from that sample and focus your effort.”.

article thumbnail

Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?

XTalks

So, this really validates what we already knew and now we have prospective results supporting that [from this trial].”.

Vaccine 103
article thumbnail

Rare Disease Diagnosis: Why Tackling the Genomic Analysis Bottleneck is Key to Advancing Precision Medicine

XTalks

We know that users don’t want to report false negatives caused by poor-quality data, which is why we’ve also introduced a genotyping feature for all curated variants contained within any gene panels of interest. HS: At Congenica, we understand the importance of quality.

Genome 98